Department of Prenatal Diagnosis Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
J Obstet Gynaecol. 2020 May;40(4):443-447. doi: 10.1080/01443615.2018.1503645. Epub 2019 Dec 6.
The aim of this study was to analyse the factors associated with fetal pleural effusion over the past five years in a single institute in the South of China. Between January 2011 and May 2016, 129 foetuses with pleural effusion were referred to the Fetal Medicine Unit in Guangzhou's Women and Children's Medical Center. Seventy-nine women accepted an invasive procedure to rule out chromosomal abnormalities, fetal anaemia, intrauterine infections or some of the submicroscopic chromosomal abnormalities. Our results showed that chromosomal anomalies occurred in 15.2% (12/79) of cases including 8 Turner syndrome (45, X) (10.1%), 3 trisomy 21 (3.8%) and 1 trisomy 13 (1.3%). Pathological microdeletion or microduplication syndrome occurred in 3 out of 36 (8.3%) prenatal samples with normal karyotype and structural defects. Eight foetuses (10.1%) affected with haemoglobin Bart's disease showed pleural effusion at second or third trimester. Two cases (2.5%) were found to have an intrauterine infection. In conclusion, fetal pleural effusion has a close correlation with chromosomal abnormality. CMA may increase the detection rate of chromosomal aberrations, especially for micro-deletion or micro-duplication syndromes. In the South of China, Thalassemia must be considered when a fetal pleural effusion is detected.Impact statement The aetiology of fetal pleural effusion includes a chromosomal abnormality, a congenital heart disease, congenital infections and a number of genetic syndromes. This is the first retrospective study to analyse the aetiology of fetal pleural effusion in one institute in the South of China. Besides the chromosomal abnormality, micro-deletion and micro-duplication syndromes were also detected in our study. We feel that thalassemia must be considered when fetal pleural effusion is detected in South China.
本研究的目的是分析过去五年在华南地区一家医院中与胎儿胸腔积液相关的因素。2011 年 1 月至 2016 年 5 月,广州妇女儿童医疗中心胎儿医学部共转诊了 129 例胸腔积液胎儿。79 名孕妇接受了侵入性检查以排除染色体异常、胎儿贫血、宫内感染或部分亚微观染色体异常。我们的结果显示,染色体异常发生在 79 例患者中的 15.2%(12/79),包括 8 例特纳综合征(45,X)(10.1%)、3 例 21 三体(3.8%)和 1 例 13 三体(1.3%)。在 36 例核型正常和结构缺陷的产前样本中,有 3 例(8.3%)发生病理性微缺失或微重复综合征。8 例(10.1%)血红蛋白 Bart's 病胎儿在妊娠中期或晚期出现胸腔积液。2 例(2.5%)发现宫内感染。总之,胎儿胸腔积液与染色体异常密切相关。CMA 可能会增加染色体异常的检出率,特别是对微缺失或微重复综合征。在中国南方,当胎儿胸腔积液时必须考虑地中海贫血。
胎儿胸腔积液的病因包括染色体异常、先天性心脏病、先天性感染和多种遗传综合征。这是第一项分析华南地区一家医院胎儿胸腔积液病因的回顾性研究。除了染色体异常,我们的研究还发现了微缺失和微重复综合征。我们认为,当在华南地区检测到胎儿胸腔积液时,必须考虑地中海贫血。